Table 3 Causative organism in reported cases of mycobacterial infection in patients receiving ruxolitinib [1, 8, 18, 19]

Mycobacterium tuberculosis

91

• Unknown site of infection

74 (81.3%)

• Disseminated tuberculosis

8 (8.8%)

• Tuberculous lymphadenitis

5 (5.5%)

• Pulmonary tuberculosis

3 (3.3%)

• Tuberculous peritonitis

1 (1.1%)

Atypical mycobacterial infections

23

• Mycobacterium avium complex

11 (47.8%)

• Unspecified atypical mycobacterium infection

9 (39.1%)

• Mycobacterium kansasii

2 (8.7%)

• Mycobacterium abscessus

1 (4.3%)